T h e enzymes required for the P-oxidation of fatty acyl-CoA are present in peroxisomes and mitochondria. Administration of hypolipidaemic compounds such as clofibrate to rodents leads to an increase in the volume and density of peroxisomes in liver cells. These proliferators also induce simultaneously the expression of genes encoding acylCoA oxidase, enoyl-CoA hydratase-hydroxyacyl-CoA dehydrogenase (multifunctional enzyme) and thiolase (3-ketoacyl-CoA thiolase). All these enzymes are responsible for long-chain and very-long-chain fatty acid P-oxidation in peroxisomes. Similar results were observed when rat hepatocytes, or liver-derived cell lines, were cultured with a peroxisome proliferator. T h e increased expression of these genes is due to the stimulation of their transcription rate. These results show that the peroxisome proliferators act on the hepatic cells and regulate the transcription through various cellular components and pathways, including peroxisome-proliferatoractivated receptor a (PPARa). After activation by specific ligands, either fibrates or fatty acid derivatives, PPARa binds to a DNA response element : peroxisome-proliferator-responsive element (PPRE), which is a direct repeat of the following consensus sequence : TGACCTXTG-ACCT, found in the promoter region of the target genes. PPARa is expressed mainly in liver, intesKey words: peroxisorne, fatty acids, P-oxidation. Abbreviations used: PI-3K phosphoinositide 3-kinase; PKC, protein kinase C; PPAR. peroxisome-prolifetator-activated receptor; PPRE. peroxisorne-proliferator-responsive element ; RXR retinoic acid X receptor. 'To whom correspondence should be addressed (e-rnail latruffe@u-bourgogne.fr).
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Introduction
Fatty acid P-oxidation, together with that of glucose, is an important pathway to provide cellular energy (in the A T P form) by producing reducing equivalents (NADH) and also to release large amount of acetyl-CoA, a precursor for several important pathways including cholesterol synthesis, farnesyl pyrophosphate and geranylgeranyl pyrophosphate precursors needed for Ras protein-membrane anchoring, and dolichol for glycosylation. Moreover, very-long-chain fatty acid /?-oxidation in peroxisomes is considered to regulate the level of arachidonic acid indirectly as a precursor of eicosanoids. Peroxisomes are ubiquitous organelles originally discovered by Rhodin in 1954 [ l ] and first isolated and characterized by De Duve's group in 1965 [2] . They appear as membrane-bound vesicles (Figure 1) and contain numerous catabolic and anabolic 
Properties of PPAR
PPARa was discovered 10 years ago by Issemann and Green [8]; subsequently, Dreyer et al. [9] cloned two other members of this subfamily v(S)
and y] belonging to the steroid receptor superfamily. PPARs are now considered to be essential transcription factors regulating key cellular functions including lipid metabolism, xenobiotic metabolism, inflammation, cell differentiation and cancer ( Figure 2 ). Their tissue distribution is well documented [lo] : PPARa is largely expressed in liver and intestine and slightly or not at all in other tissues ( Figure 2 ). In contrast, PPARy is expressed mainly in adipose tissue and less in intestine, whereas PPAR/3(G) seems to be a ubiquitous for PPARy. The biological ligands belong mostly to signalling messenger molecules produced from the arachidonic cascade pathways, namely the leukotriene LTB4 of the lipoxygenase route for PPARa or the prostaglandin A15PGJ2 of the cyclo-oxygenase route for PPARy. In contrast, PPAR/3/G is preferentially activated by unsaturated fatty acids [13] . T o elucidate the interactions between ligands and PPARs or other peroxisome binding proteins, we developed a new probe, a fluorescent bezafibrate derivative, DNS-X [ 141. This molecule is able to trigger peroxisome proliferation both in oitro [14] and in oioo [15] and to undergo a PPARa activation by transfection assays. The PPAR-DNA response element is a direct repeat motif with a consensus sequence of TGACCT(T/A)TGACCT [16] . Such a peroxisome-proliferator-responsive element (PPRE) is found in the promoter of all the genes that encode peroxisomal fatty acid P-oxidation enzymes.
With others, we showed that the PPAR-PPRE interaction leads to transcriptional activation [17] . For this to occur, PPARa must be heterodimerized with retinoic acid X receptor (RXRa), another transcription factor activated by 9-cis retinoic acid.
PPARa-dependent transcriptional activation of genes encoding peroxioomal fatty acid fi-oxidation enzymes
In rat liver, the level of these specific mRNAs is strongly increased after treatment with the peroxisome proliferator ciprofibrate [7] . Indeed this high level of mRNAs is observed for the whole metabolic pathway, including acyl-CoA synthetase, the membrane ABC transporter, ALDRP (adrenoleukodystrophy related protein), acyl-CoA oxidase, the multifunctional enzyme (hydratasedehydrogenase), thiolase (3-ketoacyl-CoA thiolase) and acetyl/octanoyl carnitine transferases (Figure 2 ). T o some extent this overall transcription increase is reminiscent of bacterial operon induction. Recently we have been interested in the regulation of the thiolase B gene. This gene is strongly activated by peroxisome proliferators [ 181 and shows a PPRE in its promoter (Figure 3 ) at position -669/-681 [19] . Thiolase is the last enzyme of the fatty acid /3-oxidation process producing acetyl-CoA and a fatty acid shortened by two carbons per cycle. Although PPARa interacts with thiolase B PPRE, the binding and the transcriptional effects of HNF-4 are stronger on the promoter [20] , indicating a discrepancy between thiolase and the other two enzymes encoded by genes of the 8-oxidation pathway.
Modulation of PPARa activity by phosphorylation
Among the various possibilities of protein modulation i.e. transcriptional and translational regulation, ligand-mediated allosteric changes and protein-protein interactions, the phosphorylation/dephosphorylation process is an important mechanism of modulation, which is also valid for transcription factors [21] . Indeed, PPARa is phosphorylated in rat Fao hepatoma cells [22] . This phosphorylation is enhanced by cell treatment with ciprofibrate, a peroxisome proliferator. T h e consequence of PPARa phosphorylation on a peroxisome marker, the acyl-CoA oxidase encoded by a PPARa target gene, is a decrease in acyl-CoA oxidase activity [22] . Other reports showed that a MAP-kinase-dependent phosphorylation occurs at least at the serine-12 located at the N-terminal region A/B transactivating domain [23] . Moreover, the phosphorylation of PPARa is insulin dependent [24] and PPARa activity is modulated by an inhibitor under the control of a kinase complex regulated by growth hormone [25] . Interestingly, there is similar phosphorylation of PPARy in preadipocytes/adipocytes, where PPARy phosphorylation is dependent on MAP kinase and leads to a decrease in PPARy-mediated preadipocyte differentiation into adipocytes [26] .
Protein kinase C (PKC) mediates peroxisome proliferator effects
Until recently there was little information on the effect of peroxisome proliferators on signal transduction. Several years ago it was reported that P K C was stimulated in vitro by peroxisome proliferators [27] . We reported an increase in phosphorylation of several cellular phosphoproteins in the presence of ciprofibrate [28] . Recently, by using Fao-permeabilized cells, we reported that ciprofibrate in vivo stimulates the PKCdependent phosphorylation of a specific substrate [29] . In contrast, in cells pretreated with ciprofibrate, a particulate fraction contains both kinase activity and kinase substrate because the 32P labelling in vitro leads to an increase in the phosphorylation band 85 kDa of protein, in agreement with the implication of P K C [29] .
Attempts to identify the p85 polypeptide strongly suggest an identity with a regulatory component of the phosphoinositide 3-kinase (PI-3K) having a molecular mass of 85 kDa [30] 
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Latruffe, unpublished work). In this case the ciprofibrate-dependent activation of P K C would recruit both p85 (the regulatory subunit) and pl10 (the catalytic subunit) of PI-3K [31] from the membrane to allow the activation of protein kinase B (PKB = Akt) leading to the triggering of the phosphoinositide signalling cascade [32] . This mechanism would be consistent with a concerted and reciprocal regulation of glucose and fatty acid metabolism [33] . Whereas fatty acid P-oxidation [34] .
Finally, other evidence suggests that the level of ciprofibrate-sensitive thiolase mRNA is markedly decreased when cells are exposed to PKC inhibitors [35] . This finding strongly supports the view that fibrate-modulated PKC activity might be important in the regulation of peroxisomal fatty acid /I-oxidation.
Conclusions
The peroxisomal fatty acid /I-oxidation pathway is regulated by peroxisome proliferators, especially by hypolipidaemic agents of the fibrate family through PPARu, which can be modulated by a ligand-activated process, by covalent phosphorylation and through signal transduction mechanisms involving mitogen-activated protein (' MAP ') kinase, PKC and, possibly, PI-3K.
